President-elect Trump promised to clamp down on high drug prices by creating “new bidding procedures for the drug industry.”
Trump said during a press conference Wednesday that the way the country buys drugs needs to be revamped. He didn’t elaborate on specific bidding procedures, but he previously has called for Medicare to negotiate for lower drug prices. That practice is currently prohibited.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.
